Personal profile
Research interests
Dr. Monika Joshi’s research focus is in the field of genitourinary tumors, particularly in the field of immunotherapy and targeted therapy.
Clinical interests
Dr. Monika Joshi developed clinical and translational expertise in genitourinary malignancies. This experience has positioned her to undertake several innovative clinical trials with multiple collaborations and national participation. She is the disease team co-leader for the genitourinary diseases group at Penn State Cancer Institute. In addition she holds regional and national leadership roles as the co-chair for the genitourinary committee for the Big Ten Cancer Research Consortium and is also as a representative for the Pennsylvania Governor's Advisory Panel on Genetics and Genomics.
Dr. Joshi has a keen interest in developing clinical trials with novel immunotherapeutic combinations and identifying predictive and prognostic biomarkers.
Professional information
Certification, Educational Commission for Foreign Medical Graduates (ECFMG), 2006
Education/Academic qualification
Fellowship, Penn State Health Milton S. Hershey Medical Center
… → 2013
Residency, UPMC Pinnacle
… → 2010
Specialist Registrar (Fellow), University Hospitals Coventry and Warwickshire NHS Trust
… → 2007
MBBS, Manipal Academy of Higher Education
… → 2001
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Active
-
Early clinial trials for Angelica herbal supplements for prostate cancer interception
Lu, J. J. (PI) & Joshi, M. (CoPI)
9/1/22 → 8/31/27
Project: Research project
-
Angelica herbal supplement AGN-Cogni.Q acute dose safety and pharmacokinetics (PK) dose-response in prostate cancer patients.
Joshi, M., Fan, T., Schell, T. D., Liu, X., Perimbeti, S., Wheelden, M., Sun, D., Desai, D., Shank, D., Strong, A. L., Raman, J. D., Liao, J., Jiang, C. & Lu, J., Mar 2026, In: Journal of Clinical Oncology. 44, p. 372 1 p.Research output: Contribution to journal › Article › peer-review
-
Antibody–drug conjugates for bladder sparing: lessons from SURE-02 trial
Mittal, K. & Joshi, M., Apr 2026, In: The Lancet Oncology. 27, 4, p. 397-399 3 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Evaluation of the safety and efficacy of daily oral Angelica gigas Nakai (AGN)-INM176 in prostate cancer patients with rising plasma PSA (phase I/II trial).
Joshi, M., Schell, T. D., Liu, X., Perimbeti, S., Wheelden, M., Polimera, H. V., Sun, D., Shank, D., Strong, A. L., Raman, J. D., Liao, J., Jiang, C. & Lu, J., Mar 2026, In: Journal of Clinical Oncology. 44, p. TPS413-TPS413Research output: Contribution to journal › Article › peer-review
-
Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
Lü, J., Jiang, C., Drabick, J. J., Joshi, M. & Perimbeti, S., Jan 2025, In: Pharmaceutical Research. 42, 1, p. 25-47 23 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
Facilitating Advance Care Planning Conversations Among Patients With Cancer and Their Care Partners Utilizing a Conversation Game: A Pilot Study
Kimbel, K., Hayes, M., Bucher, M., Calo, W. A., Garg, T., Joshi, M., Kuntz, H., Murphy, T. E., VanDyke, E., Wasserman, E. & Van Scoy, L. J., Jun 2025, In: Cancer Reports. 8, 6, e70250.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations